.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B03A_IronPreparations.B03AB07_ChondroitinSulfateIronCo.ChondroitinSulfateIronCo .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B03A_IronPreparations.B03AB07_ChondroitinSulfateIronCo.ChondroitinSulfateIronCo| name: | ChondroitinSulfateIronComplex |
| ATC code: | B03AB07 | route: | oral |
| n-compartments | 1 |
Chondroitin sulfate-iron complex is a pharmaceutical compound where chondroitin sulfate, a glycosaminoglycan commonly used in osteoarthritis, is complexed with iron to provide iron supplementation. It has been considered for the treatment of iron deficiency anemia, utilizing the chondroitin sulfate as a carrier to potentially increase gastrointestinal tolerability. This combination is not commonly approved or widely used today as an iron supplement, with very limited clinical and pharmacokinetic data published.
No published pharmacokinetic studies directly reporting chondroitin sulfate-iron complex PK parameters in humans were found. The following parameters are roughly estimated based on known oral iron salt pharmacokinetics and the absorption characteristics of similar complexes.